Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
This tag page curates 6 Insider Trading articles that analyze recent share moves, director sales, and investor bets to help you assess risk and make smarter decisions.
295 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
When a company director buys a sizable stake, investors take notice. This article breaks down the meaning behind the ...
When a figure headlines with trillionaire status and a big stock sale, investors want to know what it means for the s...
When a lockup period ends, insiders can sell their shares, creating potential price swings. This article breaks down ...
Insider moves can reveal how company insiders view the path ahead. This guide breaks down what it means when a chief ...
A Magnite insider disclosed a sizable open-market sale, sparking questions for investors. This guide breaks down what...
When a CEO steps up with a sizable open-market purchase, investors take note. We unpack what McGraw Hill's 22,000-sha...
When a top executive sells nearly 5,000 shares of Alpha and Omega Semiconductor, investors pause. This article breaks...
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...
A recent insider move at Lindblad Expeditions Holdings drew attention from investors. This article breaks down what h...
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...